MONTELUKAST SODIUM
Active substance: montelukast
TABLET · MONTELUKAST SODIUM 10 mg/1
United StatesActive
Marketing holder: Rising Pharma Holdings, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
- MONTELUKAST SODIUM · 10 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 84 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2e2d-72fc-ac92-454e71efba40,01a120c3-2e3f-7f7f-8abb-1b824a700fdb,01a120c3-2e54-74f5-9f6d-c096a8c611df,01a120c3-2e60-7a75-87ee-97a75d39b7c2,01a120c3-31a3-7334-9708-a83cedc197c9;count=72 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3672-70f9-863e-b743897a00b3,01a1208c-3dd9-7b19-aa61-7cba8a0cbe16,01a1208c-48a7-7a95-bfc8-b703d6a15dc0,01a1208c-59c6-7f7f-9cd4-7a5d815cdd40,01a1208c-a335-769c-a755-93cf73605efb;count=93 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 16571-100
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 16571-100 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 16571-100 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 16571-100 · Verified 2026-10-09 · open in source